Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation - PubMed (original) (raw)
Clinical Trial
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation
W J Riedel et al. Psychopharmacology (Berl). 1999 Feb.
Abstract
Serotonin (5-hydroxytryptamine; 5-HT) circuits may play a role in cognitive performance, particularly in learning and memory. Cognitive impairment is often seen in depressed patients, in whom 5-HT turnover in the brain is thought to be lowered. A possible human pharmacological model to study the involvement of the serotonergic system in cognitive impairment is to reduce central 5-HT synthesis through L-tryptophan depletion in healthy subjects. In this study, the cognitive effects of tryptophan depletion were assessed and whether genetically or developmentally determined vulnerability factors were predictive of the cognitive impairment induced by tryptophan depletion. Sixteen healthy volunteers with a positive family history of depression and 11 without were given 100 g of an amino acid mixture with or without tryptophan, according to a double-blind, cross-over design. Tryptophan depletion specifically impaired long-term memory performance in all subjects: delayed recall performance, recognition sensitivity, and recognition reaction times were significantly impaired after tryptophan depletion relative to placebo. Short-term memory and perceptual and psychomotor functions were unchanged. There were no differences between groups with a positive and a negative family history for depression. On the basis of these results, it is concluded that tryptophan depletion specifically impairs long-term memory formation, presumably as a result of an acute decrease in 5-HT turnover in the brain.
Similar articles
- Tryptophan depletion in normal volunteers produces selective impairments in learning and memory.
Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ. Park SB, et al. Neuropharmacology. 1994 Mar-Apr;33(3-4):575-88. doi: 10.1016/0028-3908(94)90089-2. Neuropharmacology. 1994. PMID: 7984295 Clinical Trial. - Memory impairments in humans after acute tryptophan depletion using a novel gelatin-based protein drink.
Sambeth A, Riedel WJ, Tillie DE, Blokland A, Postma A, Schmitt JA. Sambeth A, et al. J Psychopharmacol. 2009 Jan;23(1):56-64. doi: 10.1177/0269881108089577. Epub 2008 May 30. J Psychopharmacol. 2009. PMID: 18515454 Clinical Trial. - Cognition following acute tryptophan depletion: difference between first-degree relatives of bipolar disorder patients and matched healthy control volunteers.
Sobczak S, Riedel WJ, Booij I, Aan Het Rot M, Deutz NE, Honig A. Sobczak S, et al. Psychol Med. 2002 Apr;32(3):503-15. doi: 10.1017/s0033291702005342. Psychol Med. 2002. PMID: 11989995 Clinical Trial. - Tryptophan modulation and cognition.
Riedel WJ, Sobczak S, Schmitt JA. Riedel WJ, et al. Adv Exp Med Biol. 2003;527:207-13. doi: 10.1007/978-1-4615-0135-0_24. Adv Exp Med Biol. 2003. PMID: 15206734 Review. - Tryptophan, mood, and cognitive function.
Riedel WJ, Klaassen T, Schmitt JA. Riedel WJ, et al. Brain Behav Immun. 2002 Oct;16(5):581-9. doi: 10.1016/s0889-1591(02)00013-2. Brain Behav Immun. 2002. PMID: 12401472 Review.
Cited by
- Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests I. Review of biochemical aspects and poor specificity of current amino Acid formulations.
Badawy AA, Dougherty DM, Richard DM. Badawy AA, et al. Int J Tryptophan Res. 2010 Jan 1;2010(3):23-34. doi: 10.4137/ijtr.s5134. Int J Tryptophan Res. 2010. PMID: 20676231 Free PMC article. - Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.
Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Huang A, et al. Br J Cancer. 2002 Jun 5;86(11):1691-6. doi: 10.1038/sj.bjc.6600336. Br J Cancer. 2002. PMID: 12087451 Free PMC article. - Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity.
Haddad AD, Williams JM, McTavish SF, Harmer CJ. Haddad AD, et al. Psychopharmacology (Berl). 2009 Dec;207(3):499-508. doi: 10.1007/s00213-009-1693-2. Epub 2009 Oct 8. Psychopharmacology (Berl). 2009. PMID: 19813003 - Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction.
Pignalosa FC, Desiderio A, Mirra P, Nigro C, Perruolo G, Ulianich L, Formisano P, Beguinot F, Miele C, Napoli R, Fiory F. Pignalosa FC, et al. Int J Mol Sci. 2021 Nov 16;22(22):12366. doi: 10.3390/ijms222212366. Int J Mol Sci. 2021. PMID: 34830246 Free PMC article. Review. - G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits.
Azam S, Haque ME, Jakaria M, Jo SH, Kim IS, Choi DK. Azam S, et al. Cells. 2020 Feb 23;9(2):506. doi: 10.3390/cells9020506. Cells. 2020. PMID: 32102186 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical